In vitro metabolism of a mixture of (4- 14 C)pregnenolone and (17 - 3 H)pregnenolone by polycystic ovary: pathways of testosterone biosynthesis.
D015068:17-Ketosteroids / Q000096:biosynthesis; D006907:17-alpha-Hydroxypregnenolone / Q000096:biosynthesis; D000736:Androstenes / Q000096:biosynthesis; D002247:Carbon Isotopes; D002854:Chromatography, Paper; D003460:Crystallization; D003560:Cysts / Q000378:metabolism*; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000096:biosynthesis; D066298:In Vitro Techniques; D007700:Kinetics; D010049:Ovarian Diseases / Q000378:metabolism*; D010053:Ovary / Q000378:metabolism*; D011284:Pregnenolone / Q000378:metabolism*; D011374:Progesterone / Q000096:biosynthesis; D013739:Testosterone / Q000096:biosynthesis*; D014316:Tritium
D015068:17-Ketosteroids; D000736:Androstenes; D002247:Carbon Isotopes; D006908:Hydroxyprogesterones; D014316:Tritium; D006907:17-alpha-Hydroxypregnenolone; D013739:Testosterone; D003687:Dehydroepiandrosterone; D011374:Progesterone; D011284:Pregnenolone